Studies families to understand late-onset Alzheimer’s
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study focuses on people with late-onset Alzheimer’s (and some similar memory diseases) and uses a close family “informant” to share what they’ve noticed. It may help researchers learn more about these conditions and how they progress in families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (the main person in the study) have a definite or probable Alzheimer’s diagnosis, or a related condition like frontotemporal dementia or Lewy body dementia
- You have a living sibling who has probable/possible Alzheimer’s (or the study may include some rare cases of frontotemporal or Lewy body dementia without an affected sibling)
- There is at least one other living relative affected by Alzheimer’s at age 50+ or unaffected at age 60+
- An identified close family member will act as an informant and share observations about your symptoms
- You can consent yourself, or if you can’t, a legally allowed person (surrogate/proxy/next of kin) can consent for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects biological samples (blood or cells) from families where two or more members have been diagnosed with Alzheimer's disease or dementia. Researchers use these samples to identify genetic factors that may cause or increase risk for these conditions.
This study looks at people from families with inherited Alzheimer’s disease, including those who may be cognitively normal. It uses medical checkups and brain/nerve tests to better understand Alzheimer’s risk and symptoms in families with specific gene changes.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study looks at how to better predict and understand Alzheimer's disease by using advanced brain scans and spinal fluid tests. It aims to find ways to identify people who stay healthy longer despite risk factors.
This study follows people with Alzheimer’s disease and family members over 2 years. It uses regular questionnaires and medical checkups to better understand needs and health changes for patients and caregivers.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.